Privia Health Group, Inc. (NASDAQ:PRVA) Shares Bought by Hsbc Holdings PLC

Hsbc Holdings PLC increased its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 188.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 46,184 shares of the company’s stock after acquiring an additional 30,164 shares during the period. Hsbc Holdings PLC’s holdings in Privia Health Group were worth $788,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of PRVA. Nisa Investment Advisors LLC boosted its holdings in shares of Privia Health Group by 107.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after purchasing an additional 930 shares during the last quarter. Signaturefd LLC grew its position in Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after acquiring an additional 626 shares during the period. Park Place Capital Corp increased its stake in Privia Health Group by 115.4% during the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after acquiring an additional 1,335 shares during the last quarter. Covestor Ltd raised its holdings in shares of Privia Health Group by 25.5% in the 1st quarter. Covestor Ltd now owns 5,292 shares of the company’s stock worth $104,000 after purchasing an additional 1,076 shares during the period. Finally, SG Americas Securities LLC acquired a new position in shares of Privia Health Group in the 1st quarter valued at about $131,000. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Privia Health Group

In related news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total transaction of $2,500,127.00. Following the transaction, the chief executive officer now directly owns 247,771 shares in the company, valued at $4,583,763.50. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 14.20% of the stock is owned by corporate insiders.

Privia Health Group Stock Performance

NASDAQ:PRVA opened at $18.08 on Monday. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.35. The business’s 50-day simple moving average is $19.46 and its 200 day simple moving average is $18.52. The stock has a market cap of $2.16 billion, a price-to-earnings ratio of 120.53, a price-to-earnings-growth ratio of 4.24 and a beta of 0.77.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Thursday, August 8th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The company had revenue of $422.30 million for the quarter, compared to analyst estimates of $411.50 million. Privia Health Group had a return on equity of 2.42% and a net margin of 0.88%. The firm’s quarterly revenue was up 2.2% compared to the same quarter last year. During the same period in the previous year, the business posted $0.06 EPS. On average, equities research analysts predict that Privia Health Group, Inc. will post 0.16 EPS for the current year.

Analyst Upgrades and Downgrades

PRVA has been the subject of a number of research analyst reports. Royal Bank of Canada restated an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Robert W. Baird increased their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. Finally, Evercore ISI reduced their target price on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a report on Tuesday, July 9th. Two investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $24.86.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.